The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data from the ninth wave of the survey was analyzed to find out more about the prevalence of polypharmacy in different countries and to break down which factors are associated with it.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Therapy of non-tumor-related pain
Do not prescribe opioids lightly for musculoskeletal pain
- Migraine
Fremanezumab for comorbid migraine and depression
- Case study
Moyamoya disease in a 23-year-old female patient
- Dapagliflozin for T2D and heart failure
Epicardial fat reduced in patients with type 2 diabetes and HF
- A hub of biological aging
Mitochondrial dysfunction and energy metabolism
- Health Literacy
Promoting health literacy: from the abstract to the concrete level
- Pharmacological therapy
Anxiety symptoms in eating disorders
- Case study